T Cell Immunity in Malaria Pathogenesis

Malaria pathogenesis reflects a complex interplay between Plasmodium parasites and the host immune system, in which T cells occupy centre stage. CD4+ T helper 1 (Th1) cells drive protective immunity by secreting interferon-γ and supporting macrophage activation and B-cell maturation, yet their vigorous responses can also precipitate immunopathology, notably cerebral and severe anaemic manifestations. Concurrently, specialised regulatory subsets, including type I regulatory (Tr1) cells and interleukin-10-producing Th1 cells, modulate excessive inflammation, balancing parasite clearance with tissue preservation. CD8+ T cells contribute predominantly during the liver stage by cytotoxic elimination of infected hepatocytes, while their blood-stage role remains under investigation. The differentiation, longevity and trafficking of memory T cells influence both natural and vaccine-induced protection, with cytokines such as IL-27 and IL-10 shaping memory precursors and effector functions. A nuanced understanding of these T-cell dynamics underpins novel immunotherapeutic strategies and informs rational vaccine design aimed at amplifying antiparasitic efficacy while restraining pathological sequelae.

Research from Nature Portfolio

Recent studies have unveiled a critical role for superoxide dismutase 3 (SOD3) in subverting early T-cell responses during malaria. Elevated levels of SOD3, derived from activated neutrophils in infected hosts, bind directly to T cells and attenuate interleukin-2 production alongside interferon-γ secretion, thereby compromising parasite clearance. Experimental deletion of SOD3 in murine models resulted in prolonged survival and reduced parasitaemia, whereas SOD3 overexpression heightened susceptibility. These findings elucidate a parasite-driven mechanism of immune evasion that targets T-cell activation and suggest therapeutic potential in modulating SOD3 activity to reinforce host defence.

T Cell Immunity in Malaria Pathogenesis publication trend

The graph below shows the total number of articles in t cell immunity in malaria pathogenesis across all publications each year (not limited to Nature Index journals).

Technical terms

Superoxide dismutase 3 (SOD3): An extracellular enzyme secreted by neutrophils that neutralises reactive oxygen species and, in malaria, binds to T cells to suppress key cytokine responses.

Th1 cells: A subset of CD4+ T helper cells that produce interferon-γ and promote macrophage activation and cytotoxic functions essential for intracellular parasite clearance.

Type I regulatory (Tr1) cells: Induced CD4+ T cells characterised by high IL-10 production and expression of coinhibitory receptors, which temper inflammation and limit immunopathology.

IL-27: A cytokine belonging to the IL-12 family that modulates acute T-cell responses, influencing the development and maintenance of Th1 memory precursor populations.

References

1. SOD3 suppresses early cellular immune responses to parasite infection. Nature Communications (2024).
2. IL-10-producing Th1 cells possess a distinct molecular signature in malaria. Journal of Clinical Investigation (2023).
3. IL‐27 produced during acute malaria infection regulates Plasmodium‐specific memory CD4+ T cells. EMBO Molecular Medicine (2023).